Change - Announcement of Cessation::Re-designation of Chairman of the Board and Group Chief Executive Officer - Mr Chua Kheng Choon
Issuer & Securities
META HEALTH LIMITED
META HEALTH LIMITED - SG1O81915033 - 5DX
Change - Announcement of Cessation
Date &Time of Broadcast
Announcement Sub Title
Re-designation of Chairman of the Board and Group Chief Executive Officer - Mr Chua Kheng Choon
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Description (Please provide a detailed description of the event in the box below)
Re-designation of Chairman of he Board and Group Chief Executive Officer, Mr Chua Kheng Choon as SVP of Engineering.
This announcement has been prepared by Meta Health Limited (the "Company") and its contents have been reviewed by the Company's sponsor, ZICO Capital Pte. Ltd. (the "Sponsor"), in accordance with Rule 226(2)(b) of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist.
This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Mr Alex Tan, Chief Executive Officer, ZICO Capital Pte. Ltd. at 77 Robinson Road, #06-03 Robinson 77, Singapore 068896, telephone (65) 6636 4201.
Name Of Person
Chua Kheng Choon
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
As part of the Company's strategic restructuring of its management team as it endeavors to diversify and expand into the digital healthcare industry, Mr Chua will step down as an Executive Director of the Company, Chairman of the Board and Group Chief Executive Officer, and will be re-designated as SVP of Engineering, where he will continue to head the operations for the metal engineering business of the Group.
After having interviewed Mr Chua and to the best of its knowledge, the Company's Sponsor, ZICO Capital Pte. Ltd., is satisfied that, save as disclosed in this announcement, there are no other material reasons for the re-designation of Mr Chua.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chairman and Group Chief Executive Officer.
Role and responsibilities
Executive. Responsible for overseeing the overall business strategy of the Group and the conduct of the Group's daily operational directions and decisions.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Shareholding interest in the listed issuer and its subsidiaries?
Mr Chua Kheng Choon holds 7,737,666 shares of the Company and is deemed to be interested in 6,735,000 shares of the Company held in the name of his spouse, Mdm Tan Chew Hiah.
Past (for the last 5 years)
MCE Industries (Shanghai) Co., Ltd
5Digital Pte. Ltd.
Gainhealth Pte. Ltd.
Gainhealth Digital Sdn. Bhd.
Gain Foods Pte. Ltd.
MCE Technologies Holding Pte. Ltd.
MCT (Thailand) Co., Ltd.
MCE Technologies (Suzhou) Co., Ltd.
MCE Technologies Sdn. Bhd.
Metal Component Technologies (Wuxi) Co., Ltd
Metal Component Engineering (Shanghai) Co., Ltd.
MCE Corporation (Shanghai) Co., Ltd.